Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Abstract Full Text (PDF, 827K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JCB Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Tam, A. Articles by Michaelis, S. Search for Related Content PubMed PubMed Citation Articles by Tam, A. Articles by Michaelis, S. Social Bookmarking                            What's this?

© The Rockefeller University Press, 0021-9525/1998//635 $5.00
The Journal of Cell Biology, Volume 142, Number 3, , 1998 635-649

Dual Roles for Ste24p in Yeast a-Factor Maturation: NH₂-terminal Proteolysis and COOH-terminal CAAX Processing

Department of Cell Biology and Anatomy, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

Maturation of the Saccharomyces cerevisiae a-factor precursor involves COOH-terminal CAAX processing (prenylation, AAX tripeptide proteolysis, and carboxyl methylation) followed by cleavage of an NH₂-terminal extension (two sequential proteolytic processing steps). The aim of this study is to clarify the precise role of Ste24p, a membrane-spanning zinc metalloprotease, in the proteolytic processing of the a-factor precursor. We demonstrated previously that Ste24p is necessary for the first NH₂-terminal processing step by analysis of radiolabeled a-factor intermediates in vivo (Fujimura-Kamada, K., F.J. Nouvet, and S. Michaelis. 1997. J. Cell Biol. 136:271–285). In contrast, using an in vitro protease assay, others showed that Ste24p (Afc1p) and another gene product, Rce1p, share partial overlapping function as COOH-terminal CAAX proteases (Boyartchuk, V.L., M.N. Ashby, and J. Rine. 1997. Science. 275:1796–1800). Here we resolve these apparently conflicting results and provide compelling in vivo evidence that Ste24p indeed functions at two steps of a-factor maturation using two methods. First, direct analysis of a-factor biosynthetic intermediates in the double mutant (ste24 rce1) reveals a previously undetected species (P0*) that fails to be COOH terminally processed, consistent with redundant roles for Ste24p and Rce1p in COOH-terminal CAAX processing. Whereas a-factor maturation appears relatively normal in the rce1 single mutant, the ste24 single mutant accumulates an intermediate that is correctly COOH terminally processed but is defective in cleavage of the NH₂-terminal extension, demonstrating that Ste24p is also involved in NH2-terminal processing. Together, these data indicate dual roles for Ste24p and a single role for Rce1p in a-factor processing. Second, by using a novel set of ubiquitin–a-factor fusions to separate the NH₂- and COOH-terminal processing events of a-factor maturation, we provide independent evidence for the dual roles of Ste24p. We also report here the isolation of the human (Hs) Ste24p homologue, representing the first human CAAX protease to be cloned. We show that Hs Ste24p complements the mating defect of the yeast double mutant (ste24 rce1) strain, implying that like yeast Ste24p, Hs Ste24p can mediate multiple types of proteolytic events.

Key Words: CAAX processing • posttranslational modification • metalloproteinases • prenylated protein precursor • yeast mating pheromone

Abbreviations used in this paper: E, extracellular; EST, expressed sequence tag; Hs, Homo sapiens; I, intracellular; M, mature; ORF, open reading frame; Sc, Saccharomyces cerevisiae; SD, synthetic minimal medium; Sp, Schizosaccharomyces pombe; Ubi, ubiquitin; Ubp, ubiquitin-specific protease; YPD, yeast extract/peptone/dextrose medium.

MANY proteins are synthesized as precursors that undergo one or more maturation steps to attain their full activity, to acquire proper localization, or to facilitate protein–membrane or protein–protein interactions. The Saccharomyces cerevisiae mating pheromone a-factor provides an excellent model for dissecting several distinct types of posttranslational modification events. Fully mature a-factor (M)¹ is a prenylated, carboxyl-methylated dodecamer that is initially synthesized as a precursor encoded by the functionally redundant genes, MFA1 and MFA2. The a-factor precursor (P0) consists of the mature a-factor (12 residues) flanked by an NH₂-terminal extension (21 residues for Mfa1p) and a COOH-terminal CAAX motif (C, cys; A, an aliphatic residue; X, one of several residues) (Michaelis and Herskowitz, 1988). A goal of our laboratory is to define the biosynthetic intermediates and cellular components necessary for each step of a-factor biogenesis. Our current view of a-factor maturation, derived from pulse-chase and SDS-PAGE analysis of a-factor biosynthetic intermediates, is summarized in Fig. 1. Our studies have shown that a-factor biogenesis occurs in three ordered stages: (a) COOH-terminal CAAX processing, (b) NH₂-terminal proteolysis comprised of a pair of successive cleavage events, and (c) export (Chen et al., 1997b).

View larger version (28K): [in this window] [in a new window] [Download PPT slide]   Figure 1 Pathway of a-factor biogenesis. The a-factor precursor, biosynthetic intermediates, and components of the biogenesis machinery are shown. The biogenesis of a-factor is comprised of three stages, indicated at left: (a) COOH-terminal CAAX processing, (b) two sequential NH2-terminal proteolytic cleavages, and (c) export. The a-factor precursor (P0, top) consists of the mature, bioactive portion (black) flanked by an NH2-terminal extension (two shades of gray) and a COOH-terminal CAAX motif. Mature a-factor is a prenylated and carboxyl methylated dodecapeptide (M, bottom). The known a-factor biosynthetic intermediates that can be directly visualized by SDS-PAGE are designated P0, P1, P2, and M (Chen et al., 1997b). In this study, we present the previously undetected intermediate P0*. The cellular components that mediate COOH-terminal CAAX modification events (prenylation, AAX proteolysis, carboxyl methylation) are the Ram1p/Ram2p complex, Rce1p and Ste24p, and Ste14p, respectively (refer to text for more details). NH2-terminal processing involves two successive proteolytic steps. The first NH2-terminal cleavage step (P1 P2) is mediated by Ste24p (as confirmed by this study), and the second step (P2 M) requires Axl1p or Ste23p. The dual roles of Ste24p in COOH-terminal AAXing and the first NH2-terminal (P1 P2) processing step is the subject of this study.

In S. cerevisiae, the genetic analysis of mutants defective in a-factor biogenesis has facilitated the identification and characterization of the yeast CAAX processing components. These enzymes include (a) the farnesyl transferase complex (Ram1p/Ram2p); (b) the CAAX prenyl proteases that carry out AAXing (Rce1p or Ste24p [see below]); and (c) the carboxyl methyltransferase (Ste14p) (Hrycyna and Clarke, 1990; Schafer et al., 1990; He et al., 1991; Boyartchuk et al., 1997). The genes encoding mammalian CAAX processing enzymes that have been cloned to date are the rat, bovine, and human farnesyltransferases; the rat and human geranylgeranyltransferase; and the human prenyl protein carboxylmethyltransferase (Kohl et al., 1991; Andres et al., 1993; Zhang, 1994 [no. 1610]; Dai et al., 1998). In contrast, no mammalian CAAX protease genes have as yet been identified.

For a-factor, COOH-terminal CAAX processing is only the first stage of its maturation. CAAX processing of the a-factor precursor (P0) produces an intermediate (P1) that is completely modified at the COOH terminus (farnesylated, AAXed, and carboxyl methylated) but contains an intact NH₂-terminal extension (see Fig. 1). The NH₂-terminal extension is removed in two sequential and obligatorily ordered NH₂-terminal proteolytic cleavages, the first one yielding the partially processed precursor (P2), and the second cleavage generating fully mature a-factor (M). We recently showed that Ste24p is required for the first NH₂-terminal proteolytic step (P1 P2 processing) (Fujimura-Kamada et al., 1997), as discussed below. The second step (P2 M) is mediated by Axl1p and can also be carried out redundantly by Ste23p (Adames et al., 1995). Upon completion of the NH₂-terminal processing steps, mature a-factor is exported from the cell via the Ste6p transporter, a member of the ATP-binding cassette superfamily (Kuchler et al., 1989; McGrath and Varshavsky, 1989; Michaelis, 1993).

The aim of this study is to clarify the role of Ste24p, a predicted multiple membrane-spanning zinc metalloprotease, in the biogenesis of a-factor. Interestingly, the STE24 gene was identified by two independent genetic screens that assigned different functions for Ste24p in a-factor maturation (Boyartchuk et al., 1997; Fujimura-Kamada et al., 1997). Our laboratory isolated STE24 as a mating-defective mutant (hence the designation ste) in a screen specifically aimed at identifying mutants with reduced mating efficiency (Fujimura-Kamada et al., 1997). A ste24 mutant accumulates the a-factor intermediate P1 in vivo. Since P1 is fully COOH terminally modified but its NH₂-terminal extension is not proteolytically removed in the ste24 mutant, we concluded that Ste24p is required for the first NH₂-terminal processing step (P1 P2) of a-factor maturation. In a separate screen using a mutant version of a-factor with an altered CAAX motif (CAMQ instead of CVIA), Boyartchuk et al. (1997) also identified STE24 (called AFC1 in their study, a-factor converting enzyme). Using an in vitro assay for release of the AAX tripeptide, ste24 mutants showed reduced AAXing activity. Boyartchuk et al. (1997) concluded that Ste24p and a second functionally redundant protein, Rce1p, share overlapping roles in the COOH-terminal AAXing step of a-factor maturation. Rce1p, which is predicted to contain multiple membrane spans, bears no sequence similarity to Ste24p, and lacks any known protease motifs. Although STE24 was identified in genetic screens based on defective extracellular a-factor production, the two reports reached surprisingly different conclusions regarding the role of Ste24p in a-factor maturation. Likely explanations for the divergent findings are that Boyartchuk et al. (1997) examined only COOH-terminal processing in their in vitro AAXing assay and our study did not detect an AAXing defect in vivo for the single ste24 mutant because AAXing can be carried out redundantly by Rce1p.

In this study, we reconcile the apparently conflicting data for the roles of Ste24p in a-factor processing. We examine both NH₂- and COOH-terminal processing of a-factor in vivo in strains deleted for STE24 and RCE1. By directly analyzing the a-factor biosynthetic intermediates produced by the mutant strains, we provide evidence that Ste24p indeed participates in both NH₂- and COOH-terminal processing steps. In contrast, Rce1p is involved only in CAAX processing, not NH₂-terminal cleavage of a-factor. We also use an independent method employing ubiquitin (Ubi)–a-factor fusions that uncouple the NH₂- and COOH-terminal processing steps to demonstrate the dual roles for Ste24p in a-factor maturation. Finally, we report here the cloning of the human Ste24p homologue, the first mammalian CAAX prenyl protease. We show that Hs Ste24p can complement the yeast double deletion (ste24 rce1) strain for mating.

	Materials and Methods

Top Abstract Materials and Methods Results Discussion References

 
Strains and Media
The yeast strains used in this study are listed in Table I. The rce1-1:: TRP1 deletion allele, referred to as rce1, replaces codons 116 to the stop codon 315 with TRP1. Strains (SM3613, SM3614, SM3689, and SM3691) harboring the rce1 allele were constructed using one-step gene disruption by transforming SM1058, SM3103, SM2331, and SM3375, respectively, with a BamHI-XhoI fragment from pSM1285 bearing rce1-1:: TRP1, and selecting for Trp+ transformants. The ste24::LEU2 deletion allele, referred to as ste24, is a disruption of ste24 that eliminates nearly the entire coding sequence (codons 1–444 of 453 total). Strains (SM3375 and others) harboring this allele were constructed by transformation of SM2331 with linearized pSM1072 and selection of Leu⁺ transformants, as described (Fujimura-Kamada et al., 1997). All deletion strains were confirmed by Southern analysis. MAT strains bearing the single (rce1) and the double (ste24 rce1) deletions were constructed by mating-type switching of MATa strains SM3613 and SM3614, respectively, using the HO endonuclease as described (Herskowitz and Jensen, 1991). Yeast transformations were performed by the Elble method (Elble, 1992). All strains were grown at 30°C in complete yeast extract/peptone/dextrose (YPD) media, synthetic complete drop-out (SC-URA, TRP, LEU), or synthetic minimal media (SD) (Michaelis and Herskowitz, 1988; Kaiser et al., 1994).

To compare the level of extracellular a-factor for wild-type and mutant strains, we performed the a-factor spot halo assay as described previously (Nijbroek and Michaelis, 1998). Serial dilutions of concentrated a-factor (2 µl) were spotted onto a lawn of supersensitive halo tester cells (SM1086) spread on a YPD plate. Plates were incubated for 1 d at 30°C.

Plasmid Constructions
The plasmids used in this study are listed in Table II. The single-step gene disruption plasmid, pSM1285, used to generate rce1-1::TRP1 alleles, was constructed as follows: A HindIII-MluI fragment containing the RCE1 open reading frame (ORF) from pHY01 (provided by A. Toh-e, University of Tokyo, Tokyo, Japan) (Yashiroda et al., 1996) was rendered blunt-ended with Klenow and subcloned into the EcoRV-SmaI sites of pBluescriptIISK (Stratagene, La Jolla, CA) to yield pSM1284. Plasmid pSM1284 was digested with EcoRI to remove a fragment corresponding to the last 200 codons of the RCE1 ORF, which was replaced with a TRP1 EcoRI fragment from pUC18-TRP1 (Sapperstein et al., 1994) to generate pSM1285.

The linear target vector and the donor PCR fragment were cotransformed into a strain deleted for the chromosomal a-factor genes mfa1 and mfa2 (SM2331). Subsequently, candidate plasmids were screened by yeast colony PCR. In brief, crude yeast extracts were prepared by incubating a small amount of yeast cells in 60 µl of lysis buffer (0.45% NP-40, 0.45% Tween 20, 50 mM KCl, 10 mM Tris, pH 8.3, 1.5 mM MgCl₂, 0.1% gelatin, 0.3 mg/ml zymolyase) for 90 min at 37°C. The cleared lysate (5 µl) was used as the template for the PCR screening. Plasmids were recovered from yeast as described (Robzyk and Kassir, 1992). Ubi-P1, Ubi-P2, and Ubi-M are encoded by pSM1368, pSM1369, and pSM1366, respectively. All Ubi-a-factor fusion plasmids were amplified in Escherichia coli strain DH5, prepared by alkaline lysis, analyzed by restriction digests, and then confirmed by DNA sequencing.

Metabolic Labeling, Immunoprecipitation, and SDS-PAGE
To examine a-factor biosynthetic intermediates, extracts were prepared from metabolically labeled cells and radiolabeled proteins were immunoprecipitated with anti–a-factor antiserum and analyzed by SDS-PAGE, essentially as previously described (Chen et al., 1997b; Fujimura-Kamada et al., 1997). In brief, 5 OD₆₀₀ U log phase cells were harvested and resuspended in 250 µl of SD media supplemented with the appropriate amino acids. Cells were pulse labeled with 150 µCi [³⁵S]cysteine for the indicated times, and the labeling was stopped on ice by the addition of an equal volume of 2x azide buffer (40 mM methionine, 40 mM cysteine, 20 mM NaN₃, 500 mg/ml BSA). For pulse-chase experiments, chases were initiated by addition of 10 µl of 1 M cysteine per time point. Intracellular (I) and extracellular (E) fractions were processed as described (Chen et al., 1997b; Fujimura-Kamada, et al., 1997). Radiolabeled a-factor was immunoprecipitated with anti–a-factor antiserum 9-137 or 9-497, and the immunoprecipitated material was subjected to SDS-PAGE and PhosphorImager (Molecular Dynamics, Inc., Sunnyvale, CA) analysis as described (Chen et al., 1997b). To maximize the resolution between partially processed a-factor precursors, we used 16% polyacrylamide separating gels that were 13 cm in length. The half-life of each a-factor precursor (P0* or P1) was determined by quantitation of the [³⁵S] counts corresponding to the a-factor signal using ImageQuant software (Molecular Dynamics, Inc.). The 0 min time point was used as the 100% reference value for each time course experiment.

a-Factor Carboxyl Methylation Assay
The carboxyl methylation levels of the immunoprecipitated a-factor intermediates that had been cut out of a dried polyacrylamide gel were measured (Fujimura-Kamada et al., 1997). In general, the procedure involves generating double-labeled a-factor with [³H] at the carboxyl methyl group and with [³⁵S] at the prenyl cysteine. For each a-factor species (P0*, P1, P2, or M), the ratio of [³H]/[³⁵S] cpm reflects the absolute methylation level. The relative methylation level is then determined by dividing the absolute methylation level of the mutant strain by that of the wild-type strain and converting this number to a percentage value.

Specifically, this procedure was carried out in two steps. First, cells were radiolabeled, immunoprecipitated, and subjected to SDS-PAGE, as described in the previous section, with the following changes: cells were double-labeled with 50 µCi S-adenosyl-L-[³H-methyl]methionine and 150 µCi [³⁵S]cysteine for 6 min. For this assay, labeled cells were not lysed by base treatment since base hydrolysis could release the methyl esters which we wish to detect in this assay (see below). Instead, protein extracts were prepared by vortexing labeled cells at 4°C with zirconium beads in breaking buffer (50 mM potassium phosphate buffer, pH 7.4, 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 1 mM 2-mercaptoethanol, 1 mM PMSF). After separation by SDS-PAGE, the radiolabeled and immunoprecipitated a-factor intermediates were visualized by autoradiography.

Second, to determine the extent of carboxyl methylation for each a-factor intermediate, we measured the levels of [³H] and of [³⁵S] incorporation by scintillation counting. The a-factor gel bands were excised from dried gels. The [³H] labeling was determined by the vapor-phase diffusion assay, which detects volatile [³H]methyl esters (i.e., carboxyl methyl) cleaved by base hydrolysis (Xie et al., 1990; Hrycyna et al., 1991). Gel slices (P0*, P1, P2, and M) were placed in an open microfuge tube containing 150 µl of 1 M NaOH. The microfuge tube was placed inside a tightly capped 20 ml scintillation vial that contained 5 ml of scintillation fluid such that the contents of the microfuge tube did not mix with the scintillation fluid. After incubation at 37°C for 24–36 h, the released volatile [³H]methanol was measured by scintillation counting. The total amount of [³⁵S] incorporated into each a-factor species was then determined. First, the contents of the microfuge tube (including the gel slice) were neutralized with 100 µl of glacial acetic acid and then dissolved in 1 ml of Solvable (New England Nuclear Research Products, Boston, MA), a tissue solubilizer, in capped microfuge tubes at 65°C for 6 h. The [³⁵S] counts of the entire sample were then measured by liquid scintillation counting. The ratio of [³H] cpm to [³⁵S] cpm was calculated for each a-factor species to give the absolute methylation level. The relative methylation level was determined by dividing the absolute methylation level of the mutant strain by the absolute methylation level of the corresponding wild-type a-factor species.

Human STE24 Cloning
A BLAST search (Altschul et al., 1990) of the database of expressed sequence tags (ESTs) revealed several human ESTs with high amino acid similarity to S. cerevisiae (Sc) Ste24p. These ESTs represented cDNAs from many cell types. A 703-bp HindIII fragment from EST N76181 National Center for Biotechnology Information (NCBI) (no. 69928) was used to screen 3 x 10⁶ clones from a human B cell cDNA library (provided by S. Elledge, Baylor College of Medicine, Houston, TX) by standard methods (Ausubel, 1987). Nine positive clones were obtained and sequenced, each of which encoded partial ORFs corresponding to the 3' end of human STE24. The most complete Homo sapiens (Hs) clone contained an ORF encoding 383 residues and included the poly A tail. To obtain the remaining 5' Hs STE24 ORF, this clone was used in 5' rapid amplification of cDNA ends (RACE) PCR procedure with a fetal brain library according to the Marathon-Ready cDNA kit (Clontech, Palo Alto, CA). The full-length STE24 ORF was subcloned by recombination-mediated PCR cloning into a yeast plasmid such that the coding sequence of Sc STE24 was precisely replaced with that of Hs STE24. The resulting plasmid (pSM1468) contains the 5' upstream and 3' downstream sequences of the yeast STE24 ORF flanking the human STE24 ORF.

	Results

Top Abstract Materials and Methods Results Discussion References

 
Mating Phenotype and Extracellular a-Factor Production by ste24, rce1, and ste24 rce1 Mutants
To examine the roles of Ste24p and Rce1p in a-factor maturation, we first compared the extracellular a-factor produced from strains deleted for STE24 and RCE1. We used the spot halo dilution assay, which provides a semiquantitative measure of the amount of mature a-factor secreted by these strains. In this assay, extracellular a-factor causes the growth arrest of a lawn of supersensitive MAT sst2 cells, resulting in a clear zone (Michaelis and Herskowitz, 1988; Nijbroek and Michaelis, 1998). The relative amounts of a-factor produced by the different strains are compared by determining the highest dilution that yields a clear spot (Fig. 2 A). Whereas the ste24 mutant produces significantly decreased levels of extracellular a-factor (eightfold less than wild-type), the rce1 mutant is virtually indistinguishable from wild-type (Fig. 2 A). In contrast, we detect no extracellular a-factor for the double ste24 rce1 mutant. This result is consistent with the notion that Ste24p and Rce1p play redundant roles in the COOH-terminal AAXing step of a-factor maturation, such that only one gene must be intact for AAXing to occur, as proposed by Boyartchuk et al. (1997). However, the more severe phenotype of the ste24 single mutant versus the rce1 single mutant most likely reflects the additional role of Ste24p in the NH₂-terminal processing of a-factor.

View larger version (59K): [in this window] [in a new window] [Download PPT slide]   Figure 2 STE24 and RCE1 are required for the efficient production of a-factor by MATa cells. (A) a-Factor spot dilution assay. The a-factor– induced growth arrest of a MAT supersensitive (sst2) tester lawn results in a clear zone or spot. Dilutions of concentrated, extracellular a-factor produced by a wild-type strain, the single (rce1 and ste24) and double (ste24 rce1) mutants were prepared as described in the Materials and Methods and spotted onto a lawn of the MAT halo tester (SM1086) on YPD. The highest dilution yielding a clear spot is the titer of a-factor for that strain. The papillae arising in the clear spots are revertants arising from the sst2 lawn (Chan and Otte, 1982). (B) Patch mating assay. Strains bearing the single and double rce1 ste24 mutations were tested for the ability to mate with cells of the opposite mating type. Patches of the MATa or MAT strains to be tested for mating were replica-plated from a patch master plate onto a lawn of auxotrophic mating tester cells spread on minimal SD media. The growth of prototrophic diploids is indicative of mating. MAT strains do not exhibit mating defects even under stringent mating conditions (5% YPD) (data not shown). MATa strains tested are wild-type (SM1058), rce1 (SM3613), ste24 (SM3103), and rce1 ste24 (SM3614); the isogenic MAT strains tested are wild-type (SM1059), rce1 (SM3811), ste24 (SM3102), and rce1 ste24 (SM3812). The mating tester lawns are MAT (SM1068) and MATa (SM1067) and were resuspended in 5% YPD and 50% YPD, respectively, as described in the Materials and Methods.

rce1

ste24

ste24

ste24 rce1

ste24

ste24 rce1

A Novel a-Factor Intermediate (P0*) Is Observed in the Double ste24 rce1 Mutant
To directly examine the roles of STE24 and RCE1 in a-factor maturation, we compared the a-factor biosynthetic intermediates produced in strains deleted for STE24 and RCE1. Cells were metabolically labeled, and the a-factor biosynthetic intermediates were immunoprecipitated and separated by SDS-PAGE. For the wild-type strain, the typical profile of the intracellular (I) forms of a-factor includes the partially processed precursor species (P1 and P2) and mature (M) a-factor (Fig. 3 A, lane 1; refer to Fig. 1 for a description of each band). The band migrating slightly faster than M is the a-factor–related peptide (AFRP), whose biogenesis involves mechanisms and machinery distinct from those used to generate mature a-factor (Chen et al., 1997a). The extracellular (E) fraction contains exported mature (M) a-factor (Fig. 3 A, lane 1). For the rce1 mutant, the biosynthetic profile is similar to wild-type (Fig. 3 A, lane 2). Because the stepwise removal of the NH₂-terminal extension appears to be normal in the rce1 mutant, Rce1p does not play a major role in NH₂-terminal processing of a-factor. Furthermore, this apparently normal processing in the rce1 mutant is expected if Ste24p and Rce1p play redundant functions in COOH-terminal AAXing of a-factor (see below), since Ste24p would compensate for the lack of Rce1p. In contrast, the ste24 mutant has a dramatic phenotype of P1 accumulation (Fig. 3 A, lane 3), as we have also shown previously (Fujimura-Kamada et al., 1997). In the ste24 mutant, COOH-terminal AAXing is complete but the cleavage of the NH₂-terminal extension is defective, indicating that Ste24p is necessary for the first NH₂-terminal cleavage step (P1 P2) in a-factor maturation (see also Fig. 3 B). Notably, only a tiny amount of mature a-factor produced by the ste24 mutant is detected in the extracellular fraction by SDS-PAGE and autoradiography after a long exposure (Fujimura-Kamada et al., 1997); the more sensitive spot halo assay detects this low level of extracellular mature a-factor (refer to Fig. 2 A).

View larger version (41K): [in this window] [in a new window] [Download PPT slide]   Figure 3 The rce1 ste24 double mutant produces a novel a-factor intermediate, P0*, that is unmethylated. (A) To examine the a-factor biogenesis profile in wild-type and mutant strains, cells were metabolically labeled with [35S]cysteine for 5 min. Intracellular (I) and extracellular (E) fractions were separated by centrifugation and extracts were prepared as described in the Materials and Methods. Protein extracts were immunoprecipitated with anti–a-factor antiserum no. 9-137, and subjected to SDS-PAGE and PhosphorImager analysis. The previously characterized precursor species (P1, P2) and mature a-factor (M) are shown. The band migrating slightly faster than M is the a-factor– relabeled peptide (AFRP) and is discussed elsewhere (Chen et al., 1997a). The asterisk (*) marks the new a-factor intermediate P0* (refer to Fig. 1). (B) Carboxyl methylation levels of a-factor were used as an indirect measure of AAXing activity in wild-type and mutant strains. Cells were double-labeled with S-adenosyl-L- [3H-methyl]methionine and [35S]cysteine for 6 min. Total cell extracts were prepared, immunoprecipitated with anti–a-factor antiserum 9-137, and then subjected to SDS-PAGE and autoradiography. Bands representing each a-factor species (P0* or P1, P2, and M) were excised from the dried gel. The degree of methylation for each band was measured by determining the [3H]/[35S] cpm ratio. The relative methylation level was then calculated as a fraction of the corresponding species from the wild-type strain (100%). The ste14 strain is a control that lacks carboxyl methylation activity. NP, no protein was detected by autoradiography. The data are averaged from three independent experiments. Strains are wild-type (SM3310), rce1 (SM3644), ste24 (SM3286) rce1 ste24 (SM3651), and ste14 (SM1871).

ste24 rce1

ste24 rce1

Methylation can serve as an indirect AAXing assay, since AAXing is required to expose the methylation substrate, the free carboxyl of prenyl cysteine (Hrycyna and Clarke, 1992; Ashby and Rine, 1995; Hrycyna et al., 1995). We measured the degree of carboxyl methylation for each intracellular a-factor species made in wild-type and mutant strains. Cells were metabolically double-labeled with S-adenosyl-L-[³H-methyl]methionine and [³⁵S]cysteine, which label the COOH-methyl and prenyl cysteine of a-factor, respectively. Methylation levels were first normalized to protein levels ([³H]/[³⁵S]) and then calculated as a fraction of the corresponding a-factor intermediate from the wild-type strain (refer to Materials and Methods). As we have previously shown, the P1 intermediate produced by the ste24 mutant is completely methylated relative to the methylation levels of the wild-type strain (Fig. 3 B) (Fujimura-Kamada et al., 1997), indicating that this strain has AAXing activity, presumably mediated by Rce1p. In the rce1 mutant, we also detect a significant amount of methylation of P2 and M, although the levels are somewhat reduced, and the slowest migrating species (Fig. 3 B, top band) is not detectably methylated (see below). The methylation that occurs in the rce1 mutant most likely reflects the AAXing activity mediated by Ste24p. In contrast to the single mutants, the double ste24 rce1 mutant produces a single intermediate that is completely unmethylated (Fig. 3 B), and thus represents P0*, a prenylated but unAAXed biosynthetic intermediate of a-factor. We previously have not detected P0* probably because it is converted to P1 very quickly. Unexpectedly, the rce1 mutant produces a precursor species (Fig. 3 A, lane 2, top band) that is likely to be P0* because it is unmethylated (Fig. 3 B). In this case, and in contrast to P0* of the double ste24 rce1 mutant, P0* in the rce1 mutant is converted to P2 and then to M. A likely explanation is that when Ste24p recognizes P0* in the rce1 mutant, the dual roles of Ste24p permit it to cleave P0* at both the NH₂ and COOH termini to generate a P2-like intermediate that is subsequently methylated. Our conclusions from this analysis of a-factor intermediates generated in vivo are consistent with AAXing roles for both Ste24p and Rce1p, and an additional NH₂-terminal processing role for Ste24p only.

The Biosynthetic Intermediate, P0*, Is Metabolically Unstable
We have shown elsewhere that a defect in the carboxyl methylation of a-factor correlates with the metabolic instability of a-factor biosynthetic intermediates (Sapperstein et al., 1994). We compared the metabolic stability of P0* and P1 generated by the double (ste24 rce1) and single (ste24) mutants, respectively, by pulse-chase analysis (Fig. 4 A). This experiment reveals that the methylated P1 intermediate that accumulates in the ste24 mutant is metabolically stable with a half-life greater than 60 min (Fig. 4, A, lanes 7–9 and B). In contrast, the half-life of the unmethylated P0* species present in the double ste24 rce1 mutant is dramatically less (half-life of 9 min) (Fig. 4, A, lanes 10–12 and B). The biosynthetic profile and metabolic stability of the a-factor intermediates in the single rce1 mutant does not appear to be significantly different from that of the wild-type strain (Fig. 4 A, compare lanes 4–6 with 1–3).

View larger version (39K): [in this window] [in a new window] [Download PPT slide]   Figure 4 P0* is metabolically unstable. (A) Pulse-chase analysis of a-factor in wild-type and mutant strains. Cells were pulse labeled with [35S]cysteine for 5 min and chased with excess cold cysteine for the indicated times (min). Protein extracts were prepared, immunoprecipitated with anti–a-factor antiserum 9-137, and then analyzed by SDS-PAGE. Strains are wild-type (SM3310), rce1 (SM3644), ste24 (SM3286), and rce1 ste24 (SM3651). (B) Graph of a-factor precursor stability versus time. The amount of the single a-factor species (either P1 or P0*) present at each time point in the single (ste24) and double (rce1 ste24) mutants, respectively, was quantitated by PhosphorImager analysis and graphed as shown.

ste24 rce1

ste24

Characterization of a-Factor Species Produced by Ubiquitin–a-Factor Fusions
Since Ste24p appears to have dual roles in a-factor maturation involving both NH₂- and COOH-terminal steps, we sought a method to uncouple the two processing events. This goal necessitated a way to produce mature active a-factor independent of the normal NH₂-terminal processing steps. The expression of NH₂-terminally truncated MFA1 to directly generate the desired a-factor intermediates posed two problems: (a) translation requires an initiator methionine and thus would yield abnormal versions of the a-factor intermediates and (b) such MFA1 truncation mutants were expressed poorly (Nouvet, F., and S. Michaelis, unpublished data). Instead, we used a method for expressing polypeptides that does not require the initiator methionine (Bachmair et al., 1986). In this system, the ubiquitin structural gene is fused to the gene of interest, a-factor in our case. During translation, the ubiquitin moiety is recognized by ubiquitin-specific proteases (Ubp), which cleave precisely after the COOH-terminal residue of ubiquitin (Tobias and Varshavsky, 1991; Baker et al., 1992), and thus should yield the desired a-factor intermediates.

For this study, we made three ubiquitin–a-factor fusion constructs, designated here as Ubi–a-factor fusions (Fig. 5 A). We fused the ubiquitin gene to the full-length MFA1 gene (Ubi-P1), and to the truncated MFA1 corresponding either to the P2 intermediate (Ubi-P2) or to mature a-factor (Ubi-M). Ubi-P2 lacks the first seven residues of the MFA1 precursor and Ubi-M lacks the entire NH₂-terminal extension. As shown in Fig. 5 B, Ubi-P1, Ubi-P2, and Ubi-M directly generate the respective a-factor species that are depicted diagrammatically in Fig. 5 A.

View larger version (176K): [in this window] [in a new window] [Download PPT slide]   Figure 5 Processing of Ubi–a-factor fusion proteins generate the expected a-factor species. (A) Ubi–a-factor fusions. To generate Ubi– a-factor fusions, the sequence encoding a single copy of ubiquitin (Ubi) was fused precisely to the full-length a-factor gene MFA1 or to truncated MFA1 corresponding to P2 or mature a-factor, yielding Ubi-P1, Ubi-P2, and Ubi-M, respectively. In all cases, the CAAX motif was retained in the fusion construct. The site of cleavage by the ubiquitin-specific proteases (Ubp) is indicated. The shading of regions within a-factor correspond to that shown in Fig. 1. (B) Pulse-chase analysis of a-factor derived from wild-type MFA1 and Ubi– a-factor fusions. The pulse-chase experiment was carried out as described in Fig. 4, except that the anti–a-factor antiserum 9-497 was used. Chase times (min) are indicated. It should be noted that we do not detect the full-length forms of the Ubi–a-factor fusions, presumably because processing by the Ubps is cotranslational. We have observed the expected full-length Ubi–a-factor fusion upon introduction of a COOH-terminal G76 V mutation in ubiquitin that abolishes the normal cut site for the Ubps (Nouvet, F. and S. Michaelis, unpublished data). Strains bear deletions of the chromosomal a-factor genes (mfa1 mfa2) and contain plasmids harboring wild-type MFA1 (SM3683), Ubi-P1 (SM3685), Ubi-P2 (SM3686), or Ubi-M (SM3684). (C) a-Factor spot dilution assay. The amount of extracellular active a-factor produced by the Ubi–a-factor fusions was measured as described in the Fig. 2 legend. (D) Patch mating assay of Ubi– a-factor fusions. For permissive and stringent mating conditions, the mating tester lawn is MAT (SM1068) resuspended in 100% YPD and 1% YPD, respectively, as described in the Materials and Methods.

Ubi–a-Factor Fusions Provide Independent Evidence that Ste24p Plays a Critical Role in the NH₂-terminal Processing of a-Factor
We used the Ubi–a-factor fusion constructs to confirm the role of Ste24p in the first NH₂-terminal cleavage step of the a-factor precursor. To do so, we compared the processing of Ubi-P1 versus Ubi-P2 in the ste24 mutant (Fig. 6). As expected, MFA1 and Ubi-P1, which both possess the Ste24p NH₂-terminal cut site (P1 P2), are not properly processed to mature a-factor in the ste24 mutant (Fig. 6, lanes 4 and 5). In contrast, mature a-factor expressed from the Ubi-P2 construct bypasses the requirement for STE24 in the ste24 mutant (Fig. 6, lane 6). The STE24 requirement in the production of mature a-factor by Ubi-P1, but not by Ubi-P2, provides strong independent evidence for the role of Ste24p in the first NH₂-terminal cleavage step of a-factor. Interestingly, these data also verify the obligatory sequential order of the two NH₂-terminal processing steps of the a-factor precursor, reinforcing the notion that the first seven residues of the NH₂-terminal extension must be removed before Axl1p can act in the second NH₂-terminal processing step.

View larger version (26K): [in this window] [in a new window] [Download PPT slide]   Figure 6 Ubi–a-factor fusions provide independent evidence that Ste24p plays a critical role in NH2-terminal processing of a-factor. (A) Schematic representation of wild-type a-factor, Ubi-P1, and Ubi-P2, with the expected cleavages are shown. (B) Processing of Ubi–a-factor fusions is compared in the wild-type and ste24 mutant strains, as indicated. Radiolabeling and immunoprecipitation with anti–a-factor antiserum 9-497 was carried out as described in Fig. 3. Strains are wild-type and ste24 with MFA1 (SM3683 and SM3714), Ubi-P1 (SM3685 and SM3715), and Ubi-P2 (SM3686 and SM3716), respectively.

ste24

rce1

View larger version (40K): [in this window] [in a new window] [Download PPT slide]   Figure 7 Ubi-P2 confirms overlapping roles for Ste24p and Rce1p in COOH-terminal AAXing of a-factor; similar extracellular a-factor levels are produced from Ubi-P2 in the single ste24 and rce1 mutants. (A) The a-factor spot dilution assay was carried out as described in Fig. 2. The amount of a-factor derived from Ubi-P2 is roughly equivalent when the endpoint dilutions of the single rce1 and ste24 strains are compared. It is notable that the amount of a-factor derived from MFA1 differs markedly in the single rce1 and ste24 mutants (compare with Fig. 2). (B) Pulse labeling and immunoprecipitation of a-factor expressed from Ubi-P2 in wild-type and mutant strains. Cells were pulse labeled with [35S]cysteine for 2 min and the label was chased with excess cold cysteine for the indicated times (min). Immunoprecipitation of a-factor was carried out with anti–a-factor antiserum 9-497. Strains contain a plasmid harboring Ubi-P2 in the wild-type (SM3686), rce1 (SM3721), ste24 (SM3716), or rce1 ste24 (SM3726) backgrounds. (C) The diagram illustrates the predicted structure of the Ubi-P2 and Ubi-P2* species.

ste24

rce1

rce1

ste24

View larger version (33K): [in this window] [in a new window] [Download PPT slide]   Figure 8 Relative methylation levels of Ubi-P2 in wild-type and mutant strains. Carboxyl methylation of Ubi-P2–derived a-factor was used as an indirect measure of AAXing activity in wild-type and mutant strains, as described in Fig. 3 B, except that the radiolabel was chased for 0 and 30 min and immunoprecipitation of a-factor was carried out with anti–a-factor antiserum no. 9-497. The P2 or P2* bands were excised from dried gel. The data are averaged from two independent experiments. Strains contain a plasmid harboring Ubi-P2 in the wild-type (SM3686), rce1 (SM3721), ste24 (SM3716), or rce1 ste24 (SM3726) backgrounds.

The Human Ste24p Homologue Complements the S. cerevisiae ste24 Mutants

The human clone, which we designate Hs STE24, encodes a protein of 475 amino acids with 36% identity and 51% similarity to the S. cerevisiae Ste24p (Fig. 9 A). Like Ste24p of S. cerevisiae and S. pombe, Hs Ste24p has a characteristic zinc metalloprotease motif (HEXXH: H, histidine; E, glutamate; X, any amino acid), several corresponding transmembrane spans as predicted by hydropathy analysis (Fig. 9 B), and regions I, II, and III that are conserved among the homologues of this subfamily of zinc metalloproteases (Fig. 9 A) (Fleischman et al., 1995; Fujimura-Kamada et al., 1997; Kornitzer et al., 1991). Interestingly, Hs STE24 has a short stretch of residues within region I that is not present in either yeast homologue (Fig. 9 A, dashed lines). Hs Ste24p does not possess a consensus dilysine ER localization signal at its COOH terminus but does contain lysines at positions –3 and –6 from the COOH terminus (Fig. 9 A), which may reflect a degenerate ER localization signal.

View larger version (87K): [in this window] [in a new window] [Download PPT slide]   Figure 9 The human homologue of Ste24p complements mating defects of the yeast ste24 rce1 strain. (A) Amino acid alignment of Ste24p from S. cerevisiae, S. pombe, and H. sapiens. The S. pombe homologue, called Sp Ste24p here, is known as YAN5 (GenBank/EMBL/DDBJ accession no. Q10071). Residues shaded in black and gray, regions of identity and similarity, respectively. The zinc metalloprotease motif (HEXXH) is marked by asterisks (*). I, II, and III, conserved regions unique to members of the Ste24p zinc metalloprotease subfamily. Dashed line (---) within Region I, an additional region found solely within Hs Ste24p (GenBank/EMBL/DDBJ accession no. AF064867). Solid circles (•), a degenerate COOH-terminal dilysine motif. (B) Kyte and Doolittle hydropathy analysis of Sc Ste24p and Hs Ste24p. (C) The human STE24 was tested for the ability to complement the mating defect of the double rce1 ste24 mutant strain. The patch mating assay was carried out as described in Fig. 2. The lawn of mating tester cells (SM1068) was resuspended in 5% YPD diluted in sterile water. Strains are ste24 rce1 containing the vector only (SM3650), Sc STE24 (SM3653), or Hs STE24 (SM3814). Hs STE24 has also been recently cloned independently by H. Kumagai, K. Yanagisawa, and H. Komano (all from National Institute for Longevity Sciences, Aichi, Japan) (personal communication).

ste24 rce1

ste24

	Discussion

Top Abstract Materials and Methods Results Discussion References

 
Ste24p Is Involved in Two Distinct Proteolytic Maturation Steps of the a-Factor Precursor: NH₂- (P1 P2) and COOH-terminal (CAAX) Processing
The analysis of biosynthetic intermediates in a-factor biogenesis has facilitated the characterization of processing activities required for several posttranslational modifications, including the CAAX farnesyltransferase (Ram1p/ Ram2p), the prenyl cysteine carboxyl methyltransferase (Ste14p), and the a-factor P2 M protease (Axl1p) (Hrycyna and Clarke, 1990; Schafer et al., 1990; He et al., 1991; Adames et al., 1995). The present study focuses on the most recently discovered a-factor processing component, Ste24p, a transmembrane protease that has been previously assigned distinct, and seemingly disparate roles in a-factor processing, by us and others. We showed that Ste24p is required for the first NH₂-terminal cleavage step in a-factor biogenesis, the P1 P2 cleavage, by characterizing the a-factor intermediate that accumulates in a ste24 mutant (Fujimura-Kamada et al., 1997). In contrast, Boyartchuk et al. (1997) provided evidence that Ste24p and a dissimilar, but functionally redundant gene product (Rce1p) are involved at a different step, COOH-terminal CAAX processing of a-factor, using a biochemical assay. Here we investigate and present compelling evidence for the unifying hypothesis that Ste24p mediates dual steps in the maturation of the a-factor precursor: COOH-terminal CAAX processing and NH₂-terminal (P1 P2) processing. We show that Ste24p functionally overlaps with Rce1p only for CAAX processing. Our evidence for the roles of Ste24p and Rce1p in a-factor maturation is summarized below.

We demonstrate that Ste24p and Rce1p are functionally redundant for COOH-terminal CAAX processing of a-factor by the characterization of biosynthetic intermediates generated in both the ste24 and rce1 single and double mutants. A significant amount of AAXing occurs (indicated by methylation) in each of the single mutants (ste24 or rce1) but completely fails to occur in the double mutant (ste24 rce1) (refer to Fig. 3 B) (see below for a discussion of P0*). Since either STE24 or RCE1 is sufficient for AAXing, and deletion of both genes results in a complete defect in AAXing, we conclude that Ste24p and Rce1p share redundant roles in a-factor AAXing and appear to be the only CAAX proteases for a-factor in yeast.

A key finding here is the identification of the novel a-factor biosynthetic intermediate, P0*, in the double mutant (ste24 rce1). P0* is an early a-factor intermediate that is incompletely COOH terminally processed (prenylated but not AAXed or methylated). P0* is formed before P1, from which it shows only a subtle difference by gel mobility (refer to Figs. 1 and 3). The lack of methylation and metabolic instability of P0* distinguish it from P1, which is fully methylated and metabolically stable. These methylation differences between P1 and P0* stem from the absence or presence of the AAX tripeptide, respectively, which must be absent for the methyltransferase to act. The P0* species of a-factor is transient, and thus is not readily apparent in a wild-type strain. Presumably this is because each step of CAAX processing occurs in rapid succession, resulting in the fast conversion of P0* to P1; we can detect fully processed a-factor (M) even after a short 5 min of pulse labeling. The accumulation of the unmethylated (and unAAXed) P0* in the double mutant (ste24 rce1) provides the basis for our conclusion that Ste24p and Rce1p have redundant roles for the COOH-terminal AAXing of a-factor.

A role for Ste24p in NH₂-terminal processing of a-factor was implicated by a block in P1 P2 processing that results in P1 accumulation (neither P2 nor M is formed) in our initial study of the ste24 mutant (Fujimura-Kamada et al., 1997). In the present study, we provide independent confirmation that Ste24p is in fact necessary for this step by use of Ubi–a-factor fusions. The observation that production of mature a-factor from a construct that lacks the P1 P2 cut site (Ubi-P2) can bypass the Ste24p requirement for NH₂-terminal processing is consistent with the role of Ste24p in the first NH₂-terminal processing step of a-factor maturation (Fig. 6). Interestingly, although Ste24p and Rce1p function redundantly for CAAX processing of a-factor, Rce1p is unlikely to contribute to NH₂-terminal processing, based on the finding that P1 fails to be converted to P2 in the ste24 mutant where Rce1p is present (refer to Fig. 3 A).

As described above, Ste24p has dual roles in a-factor processing and functionally overlaps with Rce1p in one of these steps. This predicts that Rce1p should be dispensable for a-factor processing. Indeed, we observe that in the rce1 single mutant, the a-factor biogenesis profile is similar to wild-type; P2 and M are generated at similar rates in the rce1 mutant as in a wild-type strain and export of M is also indistinguishable in these two strains (refer to Fig. 3 A and Fig. 2).

Having established here that Ste24p participates in two distinct proteolytic processing steps for a-factor, we can explain the previous discrepant findings for the role of Ste24p (Boyartchuk et al., 1997; Fujimura-Kamada et al., 1997). These were due to (a) the use of two different assays and (b) the complexity arising from the situation that one protein, Ste24p, carries out two functions and that two proteins, Rce1p and Ste24p, mediate a common step. Our combined approach of examining the NH₂- and COOH-terminal processing steps of a-factor in strains deleted for STE24 and RCE1 has now resolved this issue.

a-Factor Production and Mating in ste24 and rce1 Single and Double Mutants
In light of our current view of dual functions for Ste24p (COOH-terminal AAXing and NH₂-terminal cleavage) and a single function for Rce1p (COOH-terminal AAXing), we can reevaluate the mature a-factor production and mating phenotypes of the ste24 and rce1 single and double mutants (Fig. 2). The double mutant (ste24 rce1) is completely sterile because it can carry out neither COOH- nor NH₂-terminal processing, and thus does not produce any mature a-factor. As expected, the rce1 mutant has a wild-type mating efficiency because Ste24p mediates both NH₂- and COOH-terminal processing of a-factor in this strain. In contrast, the ste24 mutant has a dramatically decreased mating efficiency (5% of wild-type) (Fujimura-Kamada et al., 1997), that is due solely to a block in NH₂-terminal processing, since COOH-terminal AAXing can be carried out by Rce1p in the ste24 mutant.

The residual mating exhibited by the ste24 mutant is significant since it reflects a low level of mature a-factor production. What gene product is responsible for the residual a-factor processing in the ste24 mutant? An unknown enzyme, or possibly even Rce1p, could mediate a very low level of P1 P2 cleavage. Alternatively, the P1 P2 processing step might be bypassed at a low level by a one-step removal of the entire NH₂-terminal extension from P1. A candidate for this latter possibility is Axl1p, whose normal role is to mediate the second NH₂-terminal (P2 M) cleavage step (between N21 and Y22) in a-factor processing. Axl1p may be able to generate mature a-factor directly from P1 somewhat inefficiently (P1 M cleavage). We favor the second hypothesis because overexpression of AXL1 can significantly suppress the ste24 mating defect (Fujimura- Kamada, K., and S. Michaelis, unpublished results).

Overlapping Roles for Ste24p and Rce1p
As discussed above, the SDS-PAGE and phenotypic analyses of the rce1 and ste24 single and double mutants indicate that either Ste24p or Rce1p is sufficient for the COOH-terminal AAXing of a-factor. Using the Ubi-P2 construct to circumvent the Ste24p requirement for NH₂-terminal processing, we could investigate the individual contributions of Ste24p and Rce1p solely to the COOH-terminal AAXing of a-factor. Based upon a-factor spot dilution assays and SDS-PAGE analysis (refer to Fig. 7), we concluded that Ste24p and Rce1p each can carry out a substantial amount of the AAXing of a-factor, since the single mutants produced approximately equivalent amounts of the bioactive mature species. Although the levels of P2 methylation in the single mutants expressing Ubi-P2 are indistinguishable from one another at a later time point, at an early time point their methylation levels differ by 50% (i.e., a twofold lower level of methylation in the rce1 versus the ste24 strains for P2 [refer to Fig. 8]). This is consistent with findings for the somewhat asymmetric roles of Ste24p and Rce1p in a-factor AAXing (35 versus 60%, respectively) using an in vitro AAXing assay with a synthetic peptide substrate and membrane extracts from mutant strains (Boyartchuk et al., 1997).

It is rather surprising that Ste24p and Rce1p function redundantly in the CAAX processing of a-factor, since they are neither homologues nor do they share common consensus sequences. Whereas Ste24p possesses the HEXXH zinc metalloprotease motif, Rce1p lacks any known protease motifs. The sole resemblance between Ste24p and Rce1p is that both are extremely hydrophobic with several predicted membrane spans. This situation contrasts with another redundant pair of a-factor processing components, Axl1p and Ste23p, that are structurally similar to each other and contain the same protease motif (Adames et al., 1995). Both Axl1p and Ste23p can mediate the final cleavage step (P2 M) in a-factor maturation, accounting for >90% and <10% of processing, respectively (Adames et al., 1995).

Given the dissimilarity of Ste24p and Rce1p and that their roles do not overlap completely, it is possible that one (or both) of these proteins acts indirectly in a-factor maturation. Ste24p and/or Rce1p may regulate another protease(s) that cleaves a-factor. Because Rce1p lacks any currently known protease motifs, it may either be a cofactor involved in AAXing or it may represent a novel protease. The development of an in vitro assay with purified Ste24p (or Rce1p) and its substrate will resolve this issue. Since both candidate proteases, Ste24p and Rce1p, as well as the potential substrate, prenylated a-factor, are quite hydrophobic and likely membrane bound, the purification and assay development will be challenging.

STE24 likely encodes a protease, however, because the conserved protease motif of Ste24p is necessary to complement the mating and a-factor production defects of a ste24 mutant (Boyartchuk et al., 1997, Fujimura-Kamada et al., 1997). Furthermore, mutations in the HEXXH motif are sufficient to abolish AAXing as well as NH₂-terminal processing (data not shown). Aside from the Ste24p subfamily of unusually hydrophobic zinc metalloproteases (Fujimura-Kamada et al., 1997), only one other subclass of HEXXH multispanning membrane proteases is known, the unrelated S2P protease involved in cholesterol homeostasis (Rawson et al., 1997). Both the S2P protease and its substrate are very hydrophobic (Rawson et al., 1997). S2P releases the sterol regulatory element binding protein transcription factor by cleaving within a transmembrane span (Hua et al., 1996; Sakai et al., 1996). It will be interesting to see how such a hydrophobic protease recognizes and processes its similarly hydrophobic substrate and whether Ste24p and S2P use analogous processing mechanisms.

If Ste24p directly cleaves a-factor, then how does Ste24p cut its substrate at two distinct sites? The COOH-terminal AAXing site (between residues C32, which is prenylated, and V33) bears no resemblance to the NH₂-terminal P1 P2 processing site (between residues T7 and A8). One explanation is that the prenyl cysteine serves as a landmark or recognition site for recruitment of Ste24p and that cleavage occurs at certain nearby sites. Alternatively, Ste24p could have broad substrate specificity, like the signal peptidases that recognize hydrophobic residues (for review see Dalbey et al., 1997). Ferreting out the rules for Ste24p cleavage will require assaying a large number of defined substrates.

Since Ste24p and Rce1p are not homologues but do function redundantly in a-factor processing, it is reasonable to postulate that each enzyme recognizes subsets of overlapping substrates. Various CAAX-containing proteins possess different CAAX sequences. Specific CAAX sequences can direct farnesylation, geranylgeranylation, or even both (Moores et al., 1991; Trueblood et al., 1993, 1997; Caplin et al., 1994, 1998), which could also provide another level of substrate discrimination for Ste24p and Rce1p. Although Ste24p and Rce1p mediate processing of the a-factor CAAX box, each is also likely to promote AAXing of other yeast CAAX proteins, such as Ras or the subunit (Ste18p) of the heterotrimeric G protein that transduces the pheromone response. For example, it has been suggested that Rce1p is involved in AAXing of Ras2p, whereas Ste24p is not (Boyartchuk et al., 1997; Schmidt et al., 1998). The function of another CAAX protein, Ste18p, does not require Ste24p and Rce1p since the MAT ste24 rce1 mutant does not have a mating defect (Fig. 2 B). This suggests that (a) Ste18p does not require AAXing by Ste24p and Rce1p for its function, (b) AAXing is not necessary for Ste18p function, or (c) another unidentified CAAX protease processes Ste18p. The substrate specificities of Ste24p and Rce1p remain to be elucidated.

Insight into the Role of the NH₂-terminal Extension of a-Factor by Ubi–a-Factor Fusions
In addition to reaffirming the role of Ste24p in NH₂-terminal processing, the Ubi–a-factor fusions provided a method to verify the order of a-factor processing events and also to examine the role of the NH₂-terminal extension in the production and export of mature a-factor. First, the NH₂-terminal extension must be removed in two successive steps for production of mature a-factor. This sequence of events is based on the finding that the second NH₂-terminal processing step by Axl1p can proceed efficiently only after completion of the first NH₂-terminal cleavage, either via Ste24p or as encoded by Ubi-P2. The P1 P2 cut could expose the substrate recognition site for Axl1p. Second, since the NH₂-terminal extension is ultimately removed from a-factor before its export, a reasonable hypothesis is that the NH₂-terminal extension could play a transient role, such as targeting a-factor to its transporter, Ste6p. However, our results with Ubi-M suggest that this is not the case because Ubi-M, which lacks the NH₂-terminal extension, can still produce mature a-factor that is properly exported (refer to Fig. 5 B). Instead, the major difference between mature a-factor generated conventionally from MFA1 or unconventionally from Ubi-M is that the latter is highly metabolically unstable. An interesting possibility is that the NH₂-terminal extension plays a role in protecting a-factor from degradation. A candidate for a degradation pathway is the N-end rule pathway since the first residue (tyrosine) of mature a-factor is a destabilizing residue. Another possibility is that the NH₂-terminal extension acts as a chaperone to stabilize mature a-factor. Alternatively, the mature species derived from Ubi-M may not be methylated as efficiently as wild-type a-factor, and thus could be degraded by the same machinery that degrades P0*.

Model for Intracellular a-Factor Processing and Trafficking
Most secreted molecules, such as the other S. cerevisiae mating pheromone a-factor, undergo posttranslational processing in the lumenal compartments of the secretory pathway. In contrast, a-factor and other CAAX proteins are thought to be COOH terminally processed in the cytosol or on the cytosolic face of membranes. For example, it has been suggested that most of unprocessed Ras2p accumulates on intracellular membranes in yeast strains deleted for the CAAX proteases (ste24 rce1) (Boyartchuk et al., 1997). We have sought elsewhere to define the intracellular site where a-factor CAAX processing and NH₂-terminal processing take place (Schmidt et al., manuscript submitted for publication). In those studies, we demonstrated by subcellular fractionation and indirect immunofluorescence that the CAAX proteases (Ste24p and Rce1p) and the methyltransferase (Ste14p) are localized to the membrane of ER, presumably with their active sites facing the cytosol (Romano et al., 1998, Schmidt et al., manuscript submitted for publication). Those findings, together with the results presented here that show dual roles for Ste24p, lead to our current view of the intracellular trafficking and processing of a-factor (refer to Fig. 1). The newly synthesized a-factor precursor (P0) is prenylated by the cytosolic Ram1p/Ram2p complex, permitting its association with the ER membrane. At the cytosolic face of the ER membrane, prenylated a-factor (P0*) completes COOH-terminal CAAX processing, including AAXing by Rce1p or Ste24p, followed by carboxyl methylation by Ste14p to form P1. Next, the first NH₂-terminal cleavage step is mediated by Ste24p to yield P2. P2 is subsequently shuttled to another compartment where Axl1p (or Ste23p) (Schmidt, W.K., and S. Michaelis, unpublished data) performs the final cleavage step to generate M, which is then exported by Ste6p.

This model raises two intriguing issues. First, since Ste24p, Rce1p, and Ste14p are localized to the same intracellular membrane and act sequentially in CAAX processing, these three components could form a complex, a notion that we are presently investigating. Second, how does a prenylated protein, and a-factor in particular, traffic from the ER to its final destination (the plasma membrane)? We propose that a-factor could diffuse through the cytosol, use a carrier, or hitchhike on the outside of vesicles using the classical secretory pathway (Schmidt et al. 1998).

Human Ste24p Functions in Yeast
The COOH-terminal CAAX protein motif and its processing enzymes are conserved evolutionarily among eukaryotes. Here we report the cloning of the first mammalian CAAX prenyl protease, human (Hs) STE24. We have shown elsewhere that S. cerevisiae (Sc) STE24 defines a novel subfamily of zinc metalloproteases containing homologues from bacteria (E. coli, H. influenza) and other fungi (S. pombe) (Fujimura-Kamada et al., 1997). Additionally, ESTs that are similar to STE24 exist in many multicellular organisms (A. thaliana, C. elegans, D. melanogaster, M. musculus, H. sapiens). Members of the Ste24p subfamily are characterized by multiple membrane spans, a zinc metalloprotease motif (HEXXH), several highly conserved regions designated I, II, and III, and a COOH-terminal dilysine motif potentially involved in ER retrieval. Hs Ste24p and Sc Ste24p are 36% identical and 51% similar; Hs Ste24p shares the common features of this subfamily. However, instead of the canonical dilysine motif for ER retrieval (lysines at positions –3 and –4, or –3 and –5 from the COOH terminus), Hs Ste24p possesses what may be a degenerate dilysine motif (lysines at positions –3 and –6). It will be interesting to determine if human Ste24p, like its S. cerevisiae counterpart, is localized to the ER membrane. We expect that this will be the case, since another CAAX processing component (Ste14p methyltransferase) localizes to the ER membrane in yeast and mammalian cells (Dai et al., 1998; Romano et al., 1998).

We show by complementation that Hs Ste24p can function in yeast (Fig. 9 C). Notably, Hs Ste24p complements the mating defect of the double mutant (ste24 rce1), suggesting that it is capable of mediating not only COOH-terminal AAXing, but also NH₂-terminal processing of a-factor (Fig. 9 C). What is the physiological substrate for Hs Ste24p; is there a human homologue for a-factor that undergoes similar processing steps? Clearly, no such human substrate has been discovered to date. A potential substrate is the prelamin A precursor, which undergoes a series of maturation steps that includes COOH-terminal CAAX processing, followed by a subsequent proteolytic cleavage located 14 residues NH₂-terminal to the prenyl cysteine (Weber et al., 1989). This latter cleavage may be analogous to the NH₂-terminal processing of a-factor, which occurs at sites that are 26 and 12 residues away from the prenyl cysteine (Chen et al., 1997b). The endoprotease that processes the prelamin A precursor has yet to be cloned, although an enzymatic activity has been detected in nuclear extracts (Kilic et al., 1997). In addition to a possible role in NH₂-terminal proteolytic cleavage similar to the P1 P2 cut of the a-factor precursor, Hs Ste24p is also likely to be involved in the processing of multiple CAAX proteins found in diverse human cell types. ESTs of Hs STE24 have been identified in cDNA libraries derived from a variety of tissues (fetal brain, bone, prostate, fetal lung, pancreas tumor, human tonsillar cells enriched for germinal center B cells, retina, and heart) indicating a wide expression pattern. We anticipate that future studies will reveal the mammalian substrates of Ste24p, some of which may use a processing pathway similar to that of yeast a-factor.

	Acknowledgments

 
We thank L. Roman, R. Jensen, and members of the Michaelis laboratory for critical reading of the manuscript (all from Johns Hopkins University School of Medicine, Baltimore, MD). We are grateful to the members of the Michaelis laboratory for valuable discussions. We thank A. Toh-e and A. Varshavsky (California Institute of Technology, Pasadena, CA) for plasmids; S. Elledge for the human B cell cDNA library; L. Roman, P. Bhanot, and D. Cabin (all three from Johns Hopkins University School of Medicine) for technical advice.

This study was supported by a grant from the National Institutes of Health (GM41223) to S. Michaelis.

Submitted: 21 May 1998

Revised: 10 July 1998

Address all correspondence to Susan Michaelis, Department of Cell Biology and Anatomy, The Johns Hopkins University School of Medicine, 725 North Wolfe Street, Baltimore, MD 21205. Tel.: (410) 955-8286. Fax: (410) 955-4129. E-mail: susan_michaelis{at}qmail.bs.jhu.edu

K. Fujimara-Kamada's current address is Department of Molecular Biology, Faculty of Science, Nagoya University, Furo-cho Chikusa-ku, Nagoya, Japan 464-01.

H. Slunt's current address is Department of Neuropathology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.

S.S. Sisodia's current address is Department of Pharmacological and Physiological Science, University of Chicago, Chicago, IL 60637

	References

Top Abstract Materials and Methods Results Discussion References

 

Adames N, Blundell K, Ashby MN & Boone C. Role of yeast insulin-degrading enzyme homologs in propheromone processing and bud site selection, Science, 1995, 270, 464–467.[Abstract/Free Full Text]

Altschul SF, Gish W, Miller W, Myers EW & Lipman DJ. Basic local alignment search tool, J Mol Biol, 1990, 215, 403–410.[Medline]

Andres DA, Milatovich A, Ozcelik T, Wenzlau JM, Brown MS, Goldstein JL & Francke U. cDNA cloning of the two subunits of human CAAX farnesyltransferase and chromosomal mapping of FNTA and FNTB loci and related sequences, Genomics, 1993, 18, 105–112.[Medline]

Ashby MN & Rine J. Ras and a-factor converting enzyme, Methods Enzymol, 1995, 250, 235–250.[Medline]

Ausubel, F.M., R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl. 1987. Current Protocols in Molecular Biology. Vol. 1. Greene Publishing Associates, New York.

Bachmair A, Finley D & Varshavsky A. In vivo half-life of a protein is a function of its amino-terminal residue, Science, 1986, 234, 179–186.[Abstract/Free Full Text]

Backlund PS. Post-translational Processing of RhoA, J Biol Chem, 1997, 272, 33175–33180.[Abstract/Free Full Text]

Baker RT, Tobias JW & Varshavsky A. Ubiquitin-specific proteases of Saccharomyces cerevisiae.Cloning of UBP2 and UBP3, and functional analysis of the UBP gene family, J Biol Chem, 1992, 267, 23364–23375.[Abstract/Free Full Text]

Boyartchuk V, Ashby M & Rine J. Modulation of Ras and a-factor function by carboxyl-terminal proteolysis, Science, 1997, 275, 1796–1800.[Abstract/Free Full Text]

Caplin BE, Hettich LA & Marshall MS. Substrate characterization of the Saccharomyces cerevisiaeprotein farnesyltransferase and type-I protein geranylgeranyltransferase, Biochim Biophys Acta, 1994, 1205, 39–48.[Medline]

Caplin BE, Ohya Y & Marshall MS. Amino acid residues that define both the isoprenoid and CAAX preferences of the Saccharomyces cerevisiaeprotein farnesyltransferase. Creating the perfect farnesyltransferase, J Biol Chem, 1998, 273, 9472–9479.[Abstract/Free Full Text]

Casey PJ, Solski PA, Der CJ & Buss JE. p21ras is modified by a farnesyl isoprenoid, Proc Natl Acad Sci USA, 1989, 86, 8323–8327.[Abstract/Free Full Text]

Chan RK & Otte CA. Physiological characterization of Saccharomyces cerevisiae mutants supersensitive to G1 arrest by a-factor and alpha factor pheromones, Mol Cell Biol, 1982, 2, 21–29.[Abstract/Free Full Text]

Chen P, Choi JD, Wang R, Cotter RJ & Michaelis S. A novel a-factor-related peptide of Saccharomyces cerevisiaethat exits the cell by a Ste6p-independent mechanism, Mol Biol Cell, 1997a, 8, 1273–1291.[Abstract]

Chen P, Sapperstein SK, Choi JC & Michaelis S. Biogenesis of the Saccharomyces cerevisiae mating pheromone a-factor, J Cell Biol, 1997b, 136, 251–269.[Abstract/Free Full Text]

Clarke S. Protein isoprenylation and methylation at carboxyl-terminal cysteine residues, Annu Rev Biochem, 1992, 61, 355–386.[Medline]

Dai Q, Choy E, Chiu V, Romano J, Slivka SR, Steitz SA, Michaelis S & Philips MR. Human prenylcysteine carboxyl methyltransferase is in the endoplasmic reticulum, J Biol Chem, 1998, 273, 15030–15034.[Abstract/Free Full Text]

Dalbey RE, Lively MO, Bron S & van Dijl JM. The chemistry and enzymology of the type I signal peptidases, Protein Sci, 1997, 6, 1129–1138.[Medline]

Elble R. A simple and efficient procedure for transformation of yeasts, Biotechniques, 1992, 13, 18–20.[Medline]

Fleischman RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, Bult CJ, Tomb J-F, Dougherty BA, Merrick JM et al.. Whole-genome random sequencing and assembly of Haemophilus influenzae. , Science, 1995, 269, 496–512.[Abstract/Free Full Text]

Fujimura-Kamada K, Nouvet FJ & Michaelis S. A novel membrane-associated metalloprotease, Ste24p, is required for the first step of NH₂-terminal processing of the yeast a-factor precursor, J Cell Biol, 1997, 136, 271–285.[Abstract/Free Full Text]

He B, Chen P, Chen SY, Vancura KL, Michaelis S & Powers S. RAM2, an essential gene of yeast, and RAM1 encode the two polypeptide components of the farnesyltransferase that prenylates a-factor and Ras proteins, Proc Natl Acad Sci USA, 1991, 88, 11373–11377.[Abstract/Free Full Text]

Herskowitz I & Jensen RE. Putting the HO gene to work: Practical uses for mating-type switching, Methods Enzymol, 1991, 194, 132–146.[Medline]

Hrycyna CA & Clarke S. Farnesyl cysteine C-terminal methyltransferase activity is dependent upon the STE14 gene product in Saccharomyces cerevisiae. , Mol Cell Biol, 1990, 10, 5071–5076.[Abstract/Free Full Text]

Hrycyna CA & Clarke S. Maturation of isoprenylated proteins in Saccharomyces cerevisiae. , J Biol Chem, 1992, 267, 10457–10464.[Abstract/Free Full Text]

Hrycyna CA, Sapperstein SK, Clarke S & Michaelis S. The Saccharomyces cerevisiae STE14 gene encodes a methyltransferase that mediates C-terminal methylation of a-factor and RAS proteins, EMBO (Eur Mol Biol Organ) J, 1991, 10, 1699–1709.[Medline]

Hrycyna CA, Wait SJ, Backlund PS & Michaelis S. Use of the yeast STE14 methyltransferase, expressed as a TrpE-STE14 fusion protein in Escherichia coli, for in vitrocarboxylmethylation of isoprenylated polypeptides, Methods Enzymol, 1995, 250, 251–256.[Medline]

Hua X, Sakai J, Brown MS & Goldstein JL. Regulated cleavage of sterol regulatory element binding proteins requires sequences on both sides of the endoplasmic reticulum membrane, J Biol Chem, 1996, 271, 10379–10384.[Abstract/Free Full Text]

Johnsson N & Varshavsky A. Ubiquitin-assisted dissection of protein transport across membranes, EMBO (Eur Mol Biol Organ) J, 1994, 13, 2686–2698.[Medline]

Kaiser, C., S. Michaelis, and A. Mitchell. 1994. Methods in Yeast Genetics: A Cold Spring Harbor Course Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. 234 pp.

Kato K, Cox A, Hisaka M, Graham S, Buss J & Der C. Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity, Proc Natl Acad Sci USA, 1992, 89, 6403–6407.[Abstract/Free Full Text]

Kilic F, Dalton MB, Burrell SK, Mayer JP, Patterson SD & Sinensky M. In vitroassay and characterization of the farnesylation-dependent prelamin A endoprotease, J Biol Chem, 1997, 272, 5298–5304.[Abstract/Free Full Text]

Kohl NE, Diehl RE, Schaber MD, Rands E, Soderman DD, He B, Moores SL, Pompliano DL, Ferro NS, Powers S, Thomas K & Gibbs J. Structural homology among mammalian and Saccharomyces cerevisiaeisoprenyl-protein transferases, J Biol Chem, 1991, 266, 18884–18888.[Abstract/Free Full Text]

Kornitzer D, Teff D, Altuvi S & Oppenheim AB. Isolation, characterization, and sequence of an Escherichia coliheat shock gene, htpX, J Bacteriol, 1991, 173, 2944–2953.[Abstract/Free Full Text]

Kuchler K, Sterne RE & Thorner J. Saccharomyces cerevisiae STE6gene product: a novel pathway for protein export in eukaryotic cells, EMBO (Eur Mol Biol Organ) J, 1989, 8, 3973–3984.[Medline]

Marcus S, Caldwell GA, Miller D, Xue C-B, Naider F & Becker JM. Significance of C-terminal cysteine modifications to the biological activity of the Saccharomyces cerevisiaea-factor mating pheromone, Mol Cell Biol, 1991, 11, 3603–3612.[Abstract/Free Full Text]

McGrath JP & Varshavsky A. The yeast STE6gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein, Nature, 1989, 340, 400–404.[Medline]

Michaelis S. STE6, the yeast a-factor transporter, Semin Cell Biol, 1993, 4, 17–27.[Medline]

Michaelis S & Herskowitz I. The a-factor pheromone of Saccharomyces cerevisiaeis essential for mating, Mol Cell Biol, 1988, 8, 1309–1318.[Abstract/Free Full Text]

Moores SL, Schaber MD, Mosser SD, Rands E, O'Hara MB, Garsky VM, Marshall MS, Pompliano DL & Gibbs JB. Sequence dependence of protein isoprenylation, J Biol Chem, 1991, 266, 14603–14610.[Abstract/Free Full Text]

Muhlrad D, Hunter R & Parker R. A rapid method for localized mutagenesis of yeast genes, Yeast, 1992, 8, 79–82.[Medline]

Nijbroek GL & Michaelis S. Functional assays for analysis of yeast ste6 mutants, Methods Enzymol, 1998, 292, 193–212.[Medline]

Oldenburg KR, Vo KT, Michaelis S & Paddon C. Recombination-mediated PCR-directed plasmid construction in vivoin yeast, Nuc Acids Res, 1997, 25, 451–452.[Abstract/Free Full Text]

Rawson RB, Zelenski NG, Nijhawan D, Ye J, Sakai J, Hasan MT, Chang TY, Brown MS & Goldstein JL. Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs, Mol Cell, 1997, 1, 47–57.[Medline]

Robzyk K & Kassir Y. A simple and highly efficient procedure for rescuing autonomous plasmids from yeast, Nuc Acids Res, 1992, 20, 3790, .[Free Full Text]

Romano, J.D., W.K. Schmidt, and S. Michaelis. 1998. The Sacchromyces cerevisiae prenylcysteine carboxyl methyltransferase, Ste14p, is in the endoplasmic reticulum membrane. Mol. Biol. Cell. 9:In press.

Sakai J, Duncan EA, Rawson RB, Hua X, Brown MS & Goldstein JL. Sterol-regulated release of SREBP-2 from cell membranes requires two sequential cleavages, one within a transmembane segment, Cell, 1996, 85, 1037–1046.[Medline]

Sapperstein S, Berkower C & Michaelis S. Nucleotide sequence of the yeast STE14 gene, which encodes farnesylcysteine carboxyl methyltransferase, and demonstration of its essential role in a-factor export, Mol Cell Biol, 1994, 14, 1438–1449.[Abstract/Free Full Text]

Schafer W & Rine J. Protein prenylation: genes, enzymes, targets and functions, AnnuRev Genetics, 1992, 26, 209–237.[Medline]

Schafer WF, Trueblood C, Yang C, Mayer M, Rosenberg S, Poulter C, Kim S-H & Rine J. Enzymatic coupling of cholesterol intermediates to a mating pheromone precursor and to the Ras protein, Science, 1990, 249, 1133–1139.[Abstract/Free Full Text]

Schafer WF, Kim R, Sterne R, Thorner J, Kim S-H & Rine J. Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans, Science, 1989, 245, 379–385.[Abstract/Free Full Text]

Schmidt, W., A. Tam, K. Fujimura-Kamada, and S. Michaelis. 1998. ER membrane localization of CAAX processing components and a protease required for an NH₂-terminal proteolytic cleavage of a-factor in yeast. Proc. Natl. Acad. Sci. USA. In press.

Sikorski RS & Hieter P. A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. , Genetics, 1989, 122, 19–27.[Abstract/Free Full Text]

Tobias JW & Varshavsky A. Cloning and functional analysis of the ubiquitin-specific protease gene UBP1 of Saccharomyces cerevisiae. , J Biol Chem, 1991, 266, 12021–12028.[Abstract/Free Full Text]

Trueblood C, Ohya Y & Rine J. Genetic evidence for in vivo cross-specificity of the CaaX-box protein prenyltransferases farnesyltransferase and geranylgeranyltransferase-I in Saccharomyces cerevisiae. , Mol Cell Biol, 1993, 13, 4260–4275.[Abstract/Free Full Text]

Trueblood CE, Boyartchuk VL & Rine J. Substrate specificity determinants in the farnesyltransferase beta-subunit, Proc Natl Acad Sci USA, 1997, 94, 10774–10779.[Abstract/Free Full Text]

Weber K, Plessmann U & Traub P. Maturation of nuclear lamin A involves a specific carboxy-terminal trimming, which removes the polyisoprenylation site from the precursor; implications for the structure of the nuclear lamina, FEBS (Fed Eur Biochem Soc) Lett, 1989, 257, 411–414.

Xie H, Yamane H, Stephenson R, Ong O, Fung BK-K & Clarke S. Analysis of prenylated carboxyl-terminal cysteine methylesters in proteins, Methods (Orlando), 1990, 1, 276–282.

Yashiroda H, Oguchi T, Yasuda Y, Toh-E A & Kikuchi Y. Bul1, a new protein that binds to the Rsp5 ubiquitin ligase in Saccharomyces cerevisiae. , Mol Cell Biol, 1996, 16, 3255–3263.[Abstract]

Zhang FL & Casey PJ. Protein prenylation: molecular mechanisms and functional consequences, Annu Rev Biochem, 1996, 65, 241–269.[Medline]

CiteULike

Complore

Connotea

Del.icio.us

Digg

Facebook

Reddit

Technorati

Twitter

This article has been cited by other articles:

• Ricardo, S., Lehmann, R. (2009). An ABC Transporter Controls Export of a Drosophila Germ Cell Attractant. Science 323: 943-946 [Abstract] [Full Text]  
• Bracha-Drori, K., Shichrur, K., Lubetzky, T. C., Yalovsky, S. (2008). Functional Analysis of Arabidopsis Postprenylation CaaX Processing Enzymes and Their Function in Subcellular Protein Targeting. Plant Physiol. 148: 119-131 [Abstract] [Full Text]  
• Manandhar, S. P., Hildebrandt, E. R., Schmidt, W. K. (2007). Small-Molecule Inhibitors of the Rce1p CaaX Protease. J Biomol Screen 12: 983-993 [Abstract]  
• Leung, K. F., Baron, R., Ali, B. R., Magee, A. I., Seabra, M. C. (2007). Rab GTPases Containing a CAAX Motif Are Processed Post-geranylgeranylation by Proteolysis and Methylation. J. Biol. Chem. 282: 1487-1497 [Abstract] [Full Text]  
• Young, S. G., Meta, M., Yang, S. H., Fong, L. G. (2006). Prelamin A Farnesylation and Progeroid Syndromes. J. Biol. Chem. 281: 39741-39745 [Abstract] [Full Text]  
• Huyer, G., Kistler, A., Nouvet, F. J., George, C. M., Boyle, M. L., Michaelis, S. (2006). Saccharomyces cerevisiae a-Factor Mutants Reveal Residues Critical for Processing, Activity, and Export.. Eukaryot Cell 5: 1560-1570 [Abstract] [Full Text]  
• Plummer, L. J., Hildebrandt, E. R., Porter, S. B., Rogers, V. A., McCracken, J., Schmidt, W. K. (2006). Mutational Analysis of the Ras Converting Enzyme Reveals a Requirement for Glutamate and Histidine Residues. J. Biol. Chem. 281: 4596-4605 [Abstract] [Full Text]  
• Young, S. G., Fong, L. G., Michaelis, S. (2005). Thematic Review Series: Lipid Posttranslational Modifications. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria--new evidence suggesting that protein farnesylation could be important for disease pathogenesis. J. Lipid Res. 46: 2531-2558 [Abstract] [Full Text]  
• Mallampalli, M. P., Huyer, G., Bendale, P., Gelb, M. H., Michaelis, S. (2005). Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome. Proc. Natl. Acad. Sci. USA 102: 14416-14421 [Abstract] [Full Text]  
• Johnson, C. D., Chary, S. N., Chernoff, E. A., Zeng, Q., Running, M. P., Crowell, D. N. (2005). Protein Geranylgeranyltransferase I Is Involved in Specific Aspects of Abscisic Acid and Auxin Signaling in Arabidopsis. Plant Physiol. 139: 722-733 [Abstract] [Full Text]  
• Kim, S., Lapham, A. N., Freedman, C. G. K., Reed, T. L., Schmidt, W. K. (2005). Yeast as a Tractable Genetic System for Functional Studies of the Insulin-degrading Enzyme. J. Biol. Chem. 280: 27481-27490 [Abstract] [Full Text]  
• Yamashita, A., Kamata, R., Kawagishi, N., Nakanishi, H., Suzuki, H., Sugiura, T., Waku, K. (2005). Roles of C-Terminal Processing, and Involvement in Transacylation Reaction of Human Group IVC Phospholipase A2 (cPLA2{gamma}). J Biochem 137: 557-567 [Abstract] [Full Text]  
• Gruber, J., Lampe, T., Osborn, M., Weber, K. (2005). RNAi of FACE1 protease results in growth inhibition of human cells expressing lamin A: implications for Hutchinson-Gilford progeria syndrome. J. Cell Sci. 118: 689-696 [Abstract] [Full Text]  
• Fong, L. G., Ng, J. K., Meta, M., Cote, N., Yang, S. H., Stewart, C. L., Sullivan, T., Burghardt, A., Majumdar, S., Reue, K., Bergo, M. O., Young, S. G. (2004). Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24-deficient mice. Proc. Natl. Acad. Sci. USA 101: 18111-18116 [Abstract] [Full Text]  
• Cadinanos, J., Varela, I., Mandel, D. A., Schmidt, W. K., Diaz-Perales, A., Lopez-Otin, C., Freije, J. M. P. (2003). AtFACE-2, a functional Prenylated Protein Protease from Arabidopsis thaliana Related to Mammalian Ras-converting Enzymes. J. Biol. Chem. 278: 42091-42097 [Abstract] [Full Text]  
• Agarwal, A. K., Fryns, J.-P., Auchus, R. J., Garg, A. (2003). Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Hum Mol Genet 12: 1995-2001 [Abstract] [Full Text]  
• Bergo, M. O., Gavino, B., Ross, J., Schmidt, W. K., Hong, C., Kendall, L. V., Mohr, A., Meta, M., Genant, H., Jiang, Y., Wisner, E. R., van Bruggen, N., Carano, R. A. D., Michaelis, S., Griffey, S. M., Young, S. G. (2002). Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect. Proc. Natl. Acad. Sci. USA 99: 13049-13054 [Abstract] [Full Text]  
• Bracha, K., Lavy, M., Yalovsky, S. (2002). The Arabidopsis AtSTE24 Is a CAAX Protease with Broad Substrate Specificity. J. Biol. Chem. 277: 29856-29864 [Abstract] [Full Text]  
• Tam, A., Schmidt, W. K., Michaelis, S. (2001). The Multispanning Membrane Protein Ste24p Catalyzes CAAX Proteolysis and NH2-terminal Processing of the Yeast a-Factor Precursor. J. Biol. Chem. 276: 46798-46806 [Abstract] [Full Text]  
• Prior, I., Hancock, J. (2001). Compartmentalization of Ras proteins. J. Cell Sci. 114: 1603-1608 [Abstract]  
• Tjalsma, H., Bolhuis, A., Jongbloed, J. D. H., Bron, S., van Dijl, J. M. (2000). Signal Peptide-Dependent Protein Transport in Bacillus subtilis: a Genome-Based Survey of the Secretome. Microbiol. Mol. Biol. Rev. 64: 515-547 [Abstract] [Full Text]  
• Li, G., Alexander, H., Schneider, N., Alexander, S. (2000). Molecular basis for resistance to the anticancer drug cisplatin in Dictyostelium. Microbiology 146: 2219-2227 [Abstract] [Full Text]  
• Trueblood, C. E., Boyartchuk, V. L., Picologlou, E. A., Rozema, D., Poulter, C. D., Rine, J. (2000). The CaaX Proteases, Afc1p and Rce1p, Have Overlapping but Distinct Substrate Specificities. Mol. Cell. Biol. 20: 4381-4392 [Abstract] [Full Text]  
• Halsall, J. R., Milner, M. J., Casselton, L. A. (2000). Three Subfamilies of Pheromone and Receptor Genes Generate Multiple B Mating Specificities in the Mushroom Coprinus cinereus. Genetics 154: 1115-1123 [Abstract] [Full Text]  
• Schmidt, W. K., Tam, A., Michaelis, S. (2000). Reconstitution of the Ste24p-dependent N-terminal Proteolytic Step in Yeast a-Factor Biogenesis. J. Biol. Chem. 275: 6227-6233 [Abstract] [Full Text]  
• Fowler, T. J., DeSimone, S. M., Mitton, M. F., Kurjan, J., Raper, C. A. (1999). Multiple Sex Pheromones and Receptors of a Mushroom-producing Fungus Elicit Mating in Yeast. Mol. Biol. Cell 10: 2559-2572 [Abstract] [Full Text]  
• Otto, J. C., Kim, E., Young, S. G., Casey, P. J. (1999). Cloning and Characterization of a Mammalian Prenyl Protein-specific Protease. J. Biol. Chem. 274: 8379-8382 [Abstract] [Full Text]  
• Kim, E., Ambroziak, P., Otto, J. C., Taylor, B., Ashby, M., Shannon, K., Casey, P. J., Young, S. G. (1999). Disruption of the Mouse Rce1 Gene Results in Defective Ras Processing and Mislocalization of Ras within Cells. J. Biol. Chem. 274: 8383-8390 [Abstract] [Full Text]  
• Bergo, M. O., Leung, G. K., Ambroziak, P., Otto, J. C., Casey, P. J., Gomes, A. Q., Seabra, M. C., Young, S. G. (2001). Isoprenylcysteine Carboxyl Methyltransferase Deficiency in Mice. J. Biol. Chem. 276: 5841-5845 [Abstract] [Full Text]  
• Leung, G. K., Schmidt, W. K., Bergo, M. O., Gavino, B., Wong, D. H., Tam, A., Ashby, M. N., Michaelis, S., Young, S. G. (2001). Biochemical Studies of Zmpste24-deficient Mice. J. Biol. Chem. 276: 29051-29058 [Abstract] [Full Text]  
• Tipper, D. J., Harley, C. A (2002). Yeast Genes Controlling Responses to Topogenic Signals in a Model Transmembrane Protein. Mol. Biol. Cell 13: 1158-1174 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF, 827K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JCB Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Tam, A. Articles by Michaelis, S. Search for Related Content PubMed PubMed Citation Articles by Tam, A. Articles by Michaelis, S. Social Bookmarking                            What's this?